Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review-Reference-Cited by-同舟云学术

Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review

Published:2019-05-21 Issue:6 Volume:21 Page:
ISSN:1523-3774
Container-title:Current Rheumatology Reports
language:en
Short-container-title:Curr Rheumatol Rep

Author:

Crout Teresa M,Lennep Day S,Kishore Shweta,Majithia Vikas

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s11926-019-0828-7.pdf

Reference36 articles.

1. Sharon E, Streicher H, Goncalves P, Chen HX. Immune checkpoint inhibitors in clinical trials. Chin J Cancer. 2014;33:434–44.

2. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004;10:909–15.

3. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.

4. Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol. 2016;2:1346–53.

5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. version 2. 2018. https://www.nccn.org/professionals/physician_gls/default.aspx .

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements;Rational Pharmacotherapy in Cardiology;2024-05-24

2. An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature;International Cancer Conference Journal;2024-04-22

3. Immune checkpoint inhibitor-associated cardiovascular toxicities: A review;Heliyon;2024-03

4. Sekundäre Vaskulitiden;Die Innere Medizin;2024-01-24

5. Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis;Frontiers in Oncology;2023-09-29